Home Cart Sign in  
Chemical Structure| 1118-90-7 Chemical Structure| 1118-90-7
Chemical Structure| 1118-90-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

L-α aminoadipic acid (L-AAA), a glutamate analogue, is a specific astrocyte toxin.

Synonyms: (S)-2-Aminohexanedioic acid; L-α-Aminoadipic Acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of H-Aad-OH

CAS No. :1118-90-7
Formula : C6H11NO4
M.W : 161.16
SMILES Code : O=C(O)[C@@H](N)CCCC(O)=O
Synonyms :
(S)-2-Aminohexanedioic acid; L-α-Aminoadipic Acid
MDL No. :MFCD00002636
InChI Key :OYIFNHCXNCRBQI-BYPYZUCNSA-N
Pubchem ID :92136

Safety of H-Aad-OH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of H-Aad-OH

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1118-90-7 ]

[ 1118-90-7 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 1118-90-7 ]
  • [ 34622-39-4 ]
YieldReaction ConditionsOperation in experiment
45% With water; acetic acid; for 3h;Inert atmosphere; Reflux; (a) (S)-6-Oxo-piperidine-2-carboxylic acid A mixture of (S)-2-amino-hexanedioic acid (50 g, 310.25 mmol), acetic acid (100 mL), and water (400 mL) water was refluxed for 3 h. The unchanged starting amino acid was filtered off (24 g) and the filtrate evaporated, dissolved in hot water (50 mL) and then cooled. A crystalline precipitate formed which was filtered to provide the title intermediate (20 g, 45percent yield).
In ethanol; Step A. (S)-6-Oxopiperidine-2-carboxylic acid A solution of (S)-2-aminohexanedioic acid (470 mg, 2.9 mmol) in 20percent AcOH (5 mL) was stirred at 110° C. overnight. The solvent was removed in vacuo and the residue was dissolved in EtOH (10 mL). The unreacted amino acid was precipitated and filtered off. The filtrate was concentrated to give the crude desired product which was used directly in the next step. MS: 142.1 (M-1)-.
With acetic acid; at 110℃; Example 6. Preparation of (S)-N-((S)-l-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl) - amino)-2-oxoethyl)-N-(3-fluorophenyl)-6-oxo-l-(pyrimidin-2-yl)piperidine-2-carboxamide Compounds 19 and 20 were prepared according to the following scheme, using the following protocol. Step A. (S)-6-Oxopiperidine-2-carboxylic acid. A solution of (S)-2-aminohexanedioic acid (470 mg, 2.9 mmol) in 20percent AcOH (5 niL) was stirred at 1 10 °C overnight. The solvent was removed in vacuo and the residue was dissolved in EtOH (10 mL). The unreacted amino acid was precipitated and filtered off. The filtrate was concentrated to give the crude desired product which was used directly in the next step. MS: 142.1 (M-l)\
With acetic acid; at 110℃; A solution of (S)-2-aminohexanedioic acid (470mg, 2.9 mmol) in 20percent AcOH (5 mL) was stirred at 110 °C overnight. The solvent was removed in vacuo and the residue was dissolved in EtOH (lOmL). The unreacted amino acid was precipitated and filtered off. The filtrate was concentrated to give the crude desired product which was used directly in the next step. MS: 142.1 (M-1).
With acetic acid; at 110℃; Step A. (S)-6-Oxopiperidine-2-carboxylic acid. A solution of (S)-2-aminohexanedioic acid (470 mg, 2.9 mmol) in 20percent AcOH (5 mL) was stirred at 1 10 °C overnight. The solvent was removed in vacuo and the residue was dissolved in EtOH ( 10 mL). The unreacted amino acid was precipitated and filtered off. The filtrate was concentrated to give the crude desired product which was used directly in the next step. MS: 142. 1 (M- l )'.

  • 2
  • (S)-4-Guanidino-2-[((S)-1-{(S)-5-guanidino-2-[(S)-2-((S)-4-methyl-2-{(S)-2-[((S)-6-oxo-piperidine-2-carbonyl)-amino]-3-phenyl-propionylamino}-pentanoylamino)-3-phenyl-propionylamino]-pentanoyl}-pyrrolidine-2-carbonyl)-amino]-butyric acid [ No CAS ]
  • [ 1118-90-7 ]
  • [ 34622-39-4 ]
  • (S)-2-[(S)-1-((S)-2-{(S)-2-[(S)-2-((S)-2-Amino-3-phenyl-propionylamino)-4-methyl-pentanoylamino]-3-phenyl-propionylamino}-5-guanidino-pentanoyl)-pyrrolidine-2-carbonyl]-amino}-4-guanidino-butyric acid [ No CAS ]
  • (S)-5-Amino-5-{(S)-1-[(S)-1-((S)-1-{(S)-1-[(S)-2-((S)-1-carboxy-3-guanidino-propylcarbamoyl)-pyrrolidine-1-carbonyl]-4-guanidino-butylcarbamoyl}-2-phenyl-ethylcarbamoyl)-3-methyl-butylcarbamoyl]-2-phenyl-ethylcarbamoyl}-pentanoic acid [ No CAS ]
  • 3
  • [ 5672-83-3 ]
  • [ 1118-90-7 ]
 

Historical Records

Categories